慢性阻塞性肺疾病患者微量白蛋白尿:一项系统综述和荟萃分析

IF 2.1 4区 医学 Q3 IMMUNOLOGY
Andrea Erlac, Jesus Diez-Manglano
{"title":"慢性阻塞性肺疾病患者微量白蛋白尿:一项系统综述和荟萃分析","authors":"Andrea Erlac, Jesus Diez-Manglano","doi":"10.25259/IJMR_238_2026","DOIUrl":null,"url":null,"abstract":"<p><p>Background and objectives We conducted this systematic review and meta-analysis to determine the prevalence of microalbuminuria in patients with chronic obstructive pulmonary disease (COPD) and its association with COPD severity. Methods We conducted a literature search in PubMed, Embase, Scopus, Web of Science, Cochrane Library, and the Virtual Health Library from inception to December 31th, 2024. The search strategy was: ('chronic obstructive pulmonary disease' OR COPD OR 'chronic airflow obstruction' OR emphysema OR 'chronic bronchitis') AND (microalbuminuria OR albuminuria OR proteinuria OR 'urinary albumin creatinine ratio' OR 'urinary albumin excretion'). We included studies recruiting patients diagnosed by spirometry and providing data of microalbuminuria prevalence. We excluded studies in patients with other respiratory diseases associated with COPD, and studies published in predatory journals. The pooled prevalence of microalbuminuria was calculated using the DerSimonian-Laird binary random effects method, and the association of microalbuminuria with COPD and its severity was assessed using the Mantel-Haenszel random effects method. Results Twenty-five articles were included. The prevalence of microalbuminuria in patients with COPD was 49.3% [95% confidence interval (CI) 34.3-64.4%], which was higher than in the control population, with an estimated odds ratio of 3.94 (95% CI 2.25-6.60). In patients with severe to very severe COPD, it was higher than in those with mild to moderate COPD, with an estimated odds ratio of 4.55 (95%IC 2.85-7.28). Patients with COPD and microalbuminuria had an estimated decrease in PaO2 of 9.98 mmHg (95% CI 13.94-6.02) and an increase in PaCO2 of 8.08 mmHg (95% CI: 4.87-11.29). Interpretations and conclusions Microalbuminuria is highly prevalent in patients with COPD, with a much higher frequency than in the general population. It is more common in patients with more severe airflow obstruction and is associated with hypoxia and hypercapnia.</p>","PeriodicalId":13349,"journal":{"name":"Indian Journal of Medical Research","volume":"164 4","pages":"584-592"},"PeriodicalIF":2.1000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13650803/pdf/","citationCount":"0","resultStr":"{\"title\":\"Microalbuminuria in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.\",\"authors\":\"Andrea Erlac, Jesus Diez-Manglano\",\"doi\":\"10.25259/IJMR_238_2026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Background and objectives We conducted this systematic review and meta-analysis to determine the prevalence of microalbuminuria in patients with chronic obstructive pulmonary disease (COPD) and its association with COPD severity. Methods We conducted a literature search in PubMed, Embase, Scopus, Web of Science, Cochrane Library, and the Virtual Health Library from inception to December 31th, 2024. The search strategy was: ('chronic obstructive pulmonary disease' OR COPD OR 'chronic airflow obstruction' OR emphysema OR 'chronic bronchitis') AND (microalbuminuria OR albuminuria OR proteinuria OR 'urinary albumin creatinine ratio' OR 'urinary albumin excretion'). We included studies recruiting patients diagnosed by spirometry and providing data of microalbuminuria prevalence. We excluded studies in patients with other respiratory diseases associated with COPD, and studies published in predatory journals. The pooled prevalence of microalbuminuria was calculated using the DerSimonian-Laird binary random effects method, and the association of microalbuminuria with COPD and its severity was assessed using the Mantel-Haenszel random effects method. Results Twenty-five articles were included. The prevalence of microalbuminuria in patients with COPD was 49.3% [95% confidence interval (CI) 34.3-64.4%], which was higher than in the control population, with an estimated odds ratio of 3.94 (95% CI 2.25-6.60). In patients with severe to very severe COPD, it was higher than in those with mild to moderate COPD, with an estimated odds ratio of 4.55 (95%IC 2.85-7.28). Patients with COPD and microalbuminuria had an estimated decrease in PaO2 of 9.98 mmHg (95% CI 13.94-6.02) and an increase in PaCO2 of 8.08 mmHg (95% CI: 4.87-11.29). Interpretations and conclusions Microalbuminuria is highly prevalent in patients with COPD, with a much higher frequency than in the general population. It is more common in patients with more severe airflow obstruction and is associated with hypoxia and hypercapnia.</p>\",\"PeriodicalId\":13349,\"journal\":{\"name\":\"Indian Journal of Medical Research\",\"volume\":\"164 4\",\"pages\":\"584-592\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2026-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13650803/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian Journal of Medical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.25259/IJMR_238_2026\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Medical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25259/IJMR_238_2026","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Microalbuminuria in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.

Background and objectives We conducted this systematic review and meta-analysis to determine the prevalence of microalbuminuria in patients with chronic obstructive pulmonary disease (COPD) and its association with COPD severity. Methods We conducted a literature search in PubMed, Embase, Scopus, Web of Science, Cochrane Library, and the Virtual Health Library from inception to December 31th, 2024. The search strategy was: ('chronic obstructive pulmonary disease' OR COPD OR 'chronic airflow obstruction' OR emphysema OR 'chronic bronchitis') AND (microalbuminuria OR albuminuria OR proteinuria OR 'urinary albumin creatinine ratio' OR 'urinary albumin excretion'). We included studies recruiting patients diagnosed by spirometry and providing data of microalbuminuria prevalence. We excluded studies in patients with other respiratory diseases associated with COPD, and studies published in predatory journals. The pooled prevalence of microalbuminuria was calculated using the DerSimonian-Laird binary random effects method, and the association of microalbuminuria with COPD and its severity was assessed using the Mantel-Haenszel random effects method. Results Twenty-five articles were included. The prevalence of microalbuminuria in patients with COPD was 49.3% [95% confidence interval (CI) 34.3-64.4%], which was higher than in the control population, with an estimated odds ratio of 3.94 (95% CI 2.25-6.60). In patients with severe to very severe COPD, it was higher than in those with mild to moderate COPD, with an estimated odds ratio of 4.55 (95%IC 2.85-7.28). Patients with COPD and microalbuminuria had an estimated decrease in PaO2 of 9.98 mmHg (95% CI 13.94-6.02) and an increase in PaCO2 of 8.08 mmHg (95% CI: 4.87-11.29). Interpretations and conclusions Microalbuminuria is highly prevalent in patients with COPD, with a much higher frequency than in the general population. It is more common in patients with more severe airflow obstruction and is associated with hypoxia and hypercapnia.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.80
自引率
2.40%
发文量
191
审稿时长
3-8 weeks
期刊介绍: The Indian Journal of Medical Research (IJMR) [ISSN 0971-5916] is one of the oldest medical Journals not only in India, but probably in Asia, as it started in the year 1913. The Journal was started as a quarterly (4 issues/year) in 1913 and made bimonthly (6 issues/year) in 1958. It became monthly (12 issues/year) in the year 1964.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书